MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$3,195,987
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Research and development
1,435,135 2,924,607.5* 2,131,444 3,724,755
General and administrative
1,836,817 2,121,189* 1,898,397 2,348,227
Total operating expenses
3,271,952 5,045,796.5 4,029,841 6,072,982
Loss from operations
-3,271,952 -5,045,796.5* -4,029,841 -6,072,982
Gain on remeasurement of warrant liabilities
0 114,045* -27,816 11,126
Interest expense
6,653 2,299* 2,605 4,797
Interest income
89,354 188,445* 59,103 22,847
Other expense, net
-3,390 -20,024* -6,774 -1,850
Total other income, net
79,311 280,167* 21,908 27,326
Loss before provision for income taxes
-3,192,641 -4,765,629.5* -4,007,933 -6,045,656
Provision for income taxes
3,346 2,698* 2,840 7,954
Net loss
-3,195,987 -4,768,327.5 -4,010,773 -6,053,610
Basic EPS
-0.46 0.043 -0.06 -0.12
Basic Average Shares
7,022,945 -111,649,942 72,685,740 49,847,872
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$3,195,987 Interest income$89,354 Loss beforeprovision for income taxes-$3,192,641 Provision for income taxes$3,346 Total other income,net$79,311 Interest expense$6,653 Other expense, net-$3,390 Loss from operations-$3,271,952 Total operatingexpenses$3,271,952 General andadministrative$1,836,817 Research and development$1,435,135

REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)

REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)